A study from Weill Cornell Medicine provides new insights into a pair of proteins and their opposing functions in regulating the interferon response in hepatic stellate cells, a critical immune component in the liver’s fight against tumors.
Interim President Michael I. Kotlikoff invoked history – Cornell’s and his own – in his first State of the University address, delivered Oct. 18 in Call Auditorium during the Trustee-Council Annual Meeting.
Cornell Tech today announced that longtime supporter and Cornell alumnus Frederic Rubinstein ’52, LLB ’55 has donated $1 million to the campus’ Public Interest Technology (PiTech) program to support research that helps to…
The findings could lead to new treatments targeting a particular protein to better manage inflammation in patients who don’t respond well to existing therapies.
A new technology enables the control of specific brain circuits non-invasively with magnetic fields, according to a preclinical study from researchers at Weill Cornell Medicine, the Rockefeller University and the Icahn School of Medicine at Mount Sinai.
A study led by researchers at Weill Cornell Medicine and the New York Genome Center found that antiviral enzymes that mutate the DNA of normal and cancer cells are key promoters of early bladder cancer development.
The award funds innovative but inherently risky research endeavors that have the potential to overturn existing scientific paradigms or create new ones.
